ADPT vs CUBE · rev $179.0M vs P/E 25, rev $1.07B
Adaptive Biotechnologies Corp (ADPT) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported ADPT revenue for 2024-12-31 was $179.0M. Net income was -$159.6M. Revenue was up 5.1% from 2023-12-31 to 2024-12-31. ADPT currently screens at market cap $2.69B.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
ADPT currently screens at market cap $2.69B. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the ADPT and CUBE stock pages for the full models.
Not investment advice.